Skip to content

    • Press Release

    Previous Article
    Next Article

    Recent Articles

    Liquid-based CGP is critical for matching cancer patients to therapies
    Liquid-based CGP is critical for matching cancer patients to therapies
    Operating a speedy, high-tech NGS lab in remote Australia
    Operating a speedy, high-tech NGS lab in remote Australia
    How researchers are moving multiomics forward with Illumina technology
    Video: How researchers are moving multiomics forward with Illumina technology
    For Research Use Only

    Not for use in diagnostic procedures (except as specifically noted).

    Innovative technologies

    At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

    All trademarks are the property of Illumina, Inc. or their respective owners.
    For specific trademark information, see www.illumina.com/company/legal.html.

    © 2025 Illumina, Inc. All rights reserved.